Nano-X Imaging (NNOX) Other Non-Current Liabilities (2021 - 2026)
Nano-X Imaging (NNOX) posted quarterly Other Non-Current Liabilities of $991000.0 for Q1 2026, up 33.2% year-on-year from $744000.0 in Q1 2025, and little changed on a QoQ basis from $990000.0 in Q4 2025.
Nano-X Imaging (NNOX) Other Non-Current Liabilities (2021 - 2026) Analysis & Trends
Nano-X Imaging (NNOX) has reported Other Non-Current Liabilities for 6 consecutive years, with $991000.0 the latest figure, recorded in Q1 2026.
- Quarterly Other Non-Current Liabilities rose 33.2% year-over-year to $991000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $991000.0 (up 33.2% YoY) and the FY2025 annual result came in at $990000.0, up 42.45% from the prior year.
- Other Non-Current Liabilities was little changed at $991000.0 in Q1 2026 per NNOX's latest filing, from $990000.0 in the prior quarter.
- Over the last five years, Other Non-Current Liabilities for NNOX reached as high as $264.0 million in Q2 2022 and fell as low as $497000.0 in Q1 2023.
- A 5-year average of $32.8 million and a median of $744000.0 in 2025 frame the typical range for Other Non-Current Liabilities.
- Annual changes were most pronounced in 2022 — Other Non-Current Liabilities surged 341438.46% — and 2023, when it tumbled 99.79%.
- Year by year, Other Non-Current Liabilities stood at $8.3 million in 2022, then plunged by 92.66% to $612000.0 in 2023, then increased by 13.56% to $695000.0 in 2024, then surged by 42.45% to $990000.0 in 2025, then increased by 0.1% to $991000.0 in 2026.
- According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $991000.0, $990000.0, and $961000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Nano-X Imaging | 67.53 Mn | 23.68 Mn | -2.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 991,000.00 |
| Dec 31, 2025 | 990,000.00 |
| Sep 30, 2025 | 961,000.00 |
| Jun 30, 2025 | 845,000.00 |
| Mar 31, 2025 | 744,000.00 |
| Dec 31, 2024 | 695,000.00 |
| Sep 30, 2024 | 695,000.00 |
| Jun 30, 2024 | 642,000.00 |
| Mar 31, 2024 | 629,000.00 |
| Dec 31, 2023 | 612,000.00 |
| Sep 30, 2023 | 560,000.00 |
| Jun 30, 2023 | 558,000.00 |
| Mar 31, 2023 | 497,000.00 |
| Dec 31, 2022 | 8.34 Mn |
| Sep 30, 2022 | 54.00 Mn |
| Jun 30, 2022 | 264.00 Mn |
| Mar 31, 2022 | 222.00 Mn |
| Dec 31, 2021 | 233,000.00 |
| Sep 30, 2021 | 155,000.00 |
| Jun 30, 2021 | 94,000.00 |